Quinoline-derived amide modulators of vanilloid VR1 receptor

Details for Australian Patent Application No. 2004209456 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors not given

Agent Shelston IP

Pub. Number AU-A-2004209456

PCT Pub. Number WO2004/069792

Priority 60/444,442 03.02.03 US; Not Given 02.02.04 US

Filing date 2 February 2004

Wipo publication date 19 August 2004

International Classifications

C07D 215/38 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

11 August 2005 PCT application entered the National Phase

  PCT publication WO2004/069792 Priority application(s): WO2004/069792

26 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004209457-Antigen/antibody or ligand/receptor glycosylated specificity exchangers

2004209452-Preparation of substituted quinazolines